Trial Profile

INdividualized ITI Based on Fviii(ATE) Protection by VWF (INITIATE)

Status: Discontinued

Phase of Trial: Phase IV

Latest Information Update: 17 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Factor VIII/von Willebrand factor (Primary)
Indications Haemophilia A
Focus Therapeutic Use
Acronyms INITIATE

Most Recent Events

01 Jun 2020 According to Clinicaltrials.gov the trial was discontinued due to termination of funding from the sponsor.
14 May 2020 Status changed from recruiting to discontinued.
04 Dec 2018 Results presented at the 60th Annual Meeting and Exposition of the American Society of Hematology.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com